Exclusive Interviews

In part 3 of this exclusive interview, Dr. Eckel discusses the new PCSK9 Inhibitors and their LDL-lowering effects, and why they are beneficial for statin-intolerant patients.

In Part 1 of this exclusive interview, Dr. Eckel discusses the new PCSK9 inhibitors, treating complicated patients, and the challenges of type 2.

In part 4 of this Exclusive Interview, DIC Publisher Steve Freed asks how does the Roche system differ from other products currently on the market?

In part 3 of this Exclusive Interview, Kimberly Ward explains how to get busy healthcare providers to use the information provided by the Accu-Chek system.

In part 2 of this Exclusive Interview, Kimberly Ward explains the integration of the Accu-Check system with an Apple app and how the system's features benefit patients and physicians alike.

In part 1 of this Exclusive Interview, Kimberly Ward explains the goal and use of the Accu-Chek Connect System.

In part 5, the finale, of this Exclusive Interview, DIC publisher Steve Freed asks about the possibility of expanding the study of the nutritional supplement to address diabetic retinopathy.

Dr. Aaron Vinik joins Diabetes in Control publisher Steve Freed at the AACE 2016 convention in Orlando, Florida. In Part 6 of this Exclusive Interview, Steve asks Dr. Vinik his opinion on type 1 and SGLT-2s.

Dr. Aaron Vinik joins Diabetes in Control publisher Steve Freed at the AACE 2016 convention in Orlando, Florida. In Part 5 of this Exclusive Interview, Dr. Vinik explains the caution on the part of doctors to use the latest SGLT-2 medications despite apparent benefits.

Dr. Aaron Vinik joins Diabetes in Control publisher Steve Freed at the AACE 2016 convention in Orlando, Florida. In Part 3 of this Exclusive Interview, he explains the most important risk factors to look for when determining how to treat a patient. Aaron Vinik, MD, PhD, FCP, MACP, FACE is …